Prevalence of Hepatitis C in Hemodialysis Patients in  Indonesia

Anto Wahyudin; Ariadi Humardhani; Syafruddin A. R. Lelosutan

doi:10.20884/1.mhj.2026.5.2.17849

Anto Wahyudin Faculty of Medicine, Yarsi University, Jakarta, Indonesia
Ariadi Humardhani Department of Internal Medicine, Pasar Rebo Regional General Hospital, Jakarta, Indonesia
Syafruddin A. R. Lelosutan Department of Internal Medicine, Yarsi General Hospital, Jakarta, Indonesia

DOI: https://doi.org/10.20884/1.mhj.2026.5.2.17849

Abstract

Hepatitis C (HCV) is a blood-borne viral infection and a major cause of global morbidity and mortality. Indonesia is one of six countries contributing to 50% of the global HCV burden, with a prevalence of 0.5% in the general population. HCV infection is more frequently observed in patients with chronic kidney disease undergoing hemodialysis due to nosocomial transmission. This study employed a literature review method by searching articles published between 2015 and 2025 in Google Scholar, PubMed, and ProQuest, yielding 11 eligible studies. The analysis shows that the prevalence of HCV among hemodialysis patients in Indonesia ranges from 3.7% to 56.3%, with the highest rate reported at H. Adam Malik General Hospital Medan (56.3%) and the lowest at Banyu Bening Hospital Boyolali (3.7%). Most infected patients are male and over 45 years of age. These variations indicate that male sex and older age serve as risk factors for HCV infection in hemodialysis patients.